CALSTABIN Trademark

Trademark Overview

On Friday, May 4, 2012, a trademark application was filed for CALSTABIN with the United States Patent and Trademark Office. The USPTO has given the CALSTABIN trademark a serial number of 85616604. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 20, 2020. This trademark is owned by ARMGO Pharma, Inc.. The CALSTABIN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

PHARMACEUTICAL RESEARCH AND DEVELOPMENT; CUSTOM DESIGN AND DEVELOPMENT OF CHEMICAL REAGENTS AND BIOMEDICAL ASSAYS
calstabin

General Information

Serial Number85616604
Word MarkCALSTABIN
Filing DateFriday, May 4, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 20, 2020
Registration Number4385182
Registration DateTuesday, August 13, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 16, 2012

Trademark Statements

Goods and ServicesPHARMACEUTICAL RESEARCH AND DEVELOPMENT; CUSTOM DESIGN AND DEVELOPMENT OF CHEMICAL REAGENTS AND BIOMEDICAL ASSAYS

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 20, 2020
Primary Code042
First Use Anywhere DateWednesday, June 5, 2013
First Use In Commerce DateWednesday, June 5, 2013

Trademark Owner History

Party NameARMGO Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameARMGO Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameARMGO Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events

Event DateEvent Description
Friday, March 20, 2020CANCELLED SEC. 8 (6-YR)
Monday, August 13, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, August 13, 2013REGISTERED-PRINCIPAL REGISTER
Saturday, July 6, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 5, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, July 3, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 3, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 2, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 5, 2013USE AMENDMENT FILED
Tuesday, July 2, 2013EXTENSION 1 GRANTED
Wednesday, June 5, 2013EXTENSION 1 FILED
Friday, June 28, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 5, 2013TEAS EXTENSION RECEIVED
Wednesday, June 5, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, December 11, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 16, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 16, 2012PUBLISHED FOR OPPOSITION
Wednesday, September 26, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, September 7, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 21, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 21, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 8, 2012ASSIGNED TO LIE
Wednesday, August 1, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 24, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 24, 2012NON-FINAL ACTION E-MAILED
Thursday, May 24, 2012NON-FINAL ACTION WRITTEN
Thursday, May 24, 2012ASSIGNED TO EXAMINER
Thursday, May 10, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 8, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

calstabin development reagents biomedical chemical assays design research custom pharmaceutical